The phrase "actively evaluated" is correct and usable in written English.
It can be used when discussing processes or assessments that are ongoing or being conducted with engagement and attention.
Example: "The project's progress is actively evaluated during weekly meetings to ensure we stay on track."
Alternatives: "continuously assessed" or "regularly reviewed".
Further, a variety of risk factors are actively evaluated, including markers of the activity of atherosclerotic disease, thrombogenic risk, and genetic polymorphisms.
These functions have been actively evaluated for engineering applications.
He brushed aside the suggestion that he had spoken about sanctions with the ambassador — denials that kept him afloat within the White House even as he was being actively evaluated, they said.
One key change Twitter has announced today is also being described as a test, so is clearly being actively evaluated for effectiveness.
On the wider opportunity of synergies between Wuaki and other Rakuten companies, Roca says that the opportunities are still being "actively evaluated so see what else we can do to differentiate our proposition".
Bose himself, from the very beginning of World War II, actively evaluated the concept of revolutionary movement against the Raj, interacting with Japan and subsequently escaping to Germany to raise an Indian armed force, the Indische Legion, to fight in India against Britain.
It added, "we are actively evaluating our options in view of yesterday's meeting with the F.D.A".
Yesterday, the Lee spokesman said the private equity firm intended to sue Grant Thornton, Refco's former auditors, "and are actively evaluating potential claims against other responsible parties".
"While the legislation is well intended, we are actively evaluating possible adjustments to the noise code that will aid in our enforcement efforts," he said.
"This decision is in line with Barclays' stated objective to actively evaluate and manage our businesses, ensuring they meet strict economic and strategic criteria within the new regulatory environment," Barclays said.
Accordingly, phase II and phase III studies are actively evaluating antiangiogenic treatments in the second-line setting in NSCLC, and results are awaited.
